303 related articles for article (PubMed ID: 3869086)
1. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
Skanes V; Larsen B; Sampson-Murphy L; Farid NR
Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
[TBL] [Abstract][Full Text] [Related]
2. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
3. [Polymorphism of C4 and factor B in type I diabetes].
Blickle JF; Hauptmann G; Goetz J; Tongio MM; Mayer S; Brogard JM; Dorner M
Pathol Biol (Paris); 1988 Jun; 36(6):791-4. PubMed ID: 3047638
[TBL] [Abstract][Full Text] [Related]
4. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
5. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
6. A study of human leukocyte D locus related antigens in Graves' disease.
Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
[TBL] [Abstract][Full Text] [Related]
7. C4A gene deletion: association with Graves' disease.
Ratanachaiyavong S; Lloyd L; McGregor AM
J Mol Endocrinol; 1989 Sep; 3(2):145-53. PubMed ID: 2570594
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.
Hartung K; Baur MP; Coldewey R; Fricke M; Kalden JR; Lakomek HJ; Peter HH; Schendel D; Schneider PM; Seuchter SA
J Clin Invest; 1992 Oct; 90(4):1346-51. PubMed ID: 1401069
[TBL] [Abstract][Full Text] [Related]
9. Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls.
Bertrams J; Hintzen U; Schlicht V; Schoeps S; Gries FA; Louton TK; Baur MP
Immunobiology; 1984 May; 166(4-5):335-44. PubMed ID: 6480029
[TBL] [Abstract][Full Text] [Related]
10. C4 polymorphism and major histocompatibility complex haplotypes in IgA deficiency: association with C4A null haplotypes.
Bućin D; Truedsson L; Hammarström L; Smith CI; Sjöholm AG
Exp Clin Immunogenet; 1991; 8(4):233-41. PubMed ID: 1817567
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.
Kelly H; McCann VJ; Kay PH; Dawkins RL
Immunogenetics; 1985; 22(6):643-51. PubMed ID: 3865895
[TBL] [Abstract][Full Text] [Related]
12. MHC-extended haplotypes in families of patients with Graves' disease.
Ratanachaiyavong S; Lloyd L; Darke C; McGregor AM
Hum Immunol; 1993 Feb; 36(2):99-111. PubMed ID: 8096501
[TBL] [Abstract][Full Text] [Related]
13. HLA and insulin-dependent juvenile diabetes mellitus.
Májský A; Dvoráková L
Czech Med; 1983; 6(3):152-8. PubMed ID: 6416792
[TBL] [Abstract][Full Text] [Related]
14. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.
Matsuki K; Juji T; Tokunaga K; Naohara T; Satake M; Honda Y
J Clin Invest; 1985 Dec; 76(6):2078-83. PubMed ID: 3865934
[TBL] [Abstract][Full Text] [Related]
15. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
[TBL] [Abstract][Full Text] [Related]
16. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India.
Kumar R; Goswami R; Agarwal S; Israni N; Singh SK; Rani R
Tissue Antigens; 2007 Jun; 69(6):557-67. PubMed ID: 17498265
[TBL] [Abstract][Full Text] [Related]
17. Extended major histocompatibility complex haplotypes in type I diabetes mellitus.
Raum D; Awdeh Z; Yunis EJ; Alper CA; Gabbay KH
J Clin Invest; 1984 Aug; 74(2):449-54. PubMed ID: 6746903
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease.
Frecker M; Mercer G; Skanes VM; Farid NR
Autoimmunity; 1988; 1(4):307-15. PubMed ID: 2979624
[TBL] [Abstract][Full Text] [Related]
19. HLA and C4 polymorphism in diabetic microangiopathy.
Fletcher JA; Mijovic C; Barnett AH; Bradwell AR; Delamere J; Milles J; Wells L; Jobson S; Mackintosh P
Diabetes Res; 1987 Feb; 4(2):101-2. PubMed ID: 3495390
[TBL] [Abstract][Full Text] [Related]
20. HLA haplotypes in familial Graves' disease.
Farid NR; Moens H; Larsen B; Payne R; Saltman K; Fifield F; Ingram DW
Tissue Antigens; 1980 May; 15(5):492-500. PubMed ID: 6893771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
